2008 Request for Applications - Deadline Sept. 26

The Minnesota Partnership is requesting research applications for its next round of funding awards to total $5 million. Applicants must be co-investigators from Mayo Clinic and the University of Minnesota. Awards will be announced on or before January 2009.

Minnesota tries to keep a med tech edge

BioBusiness Alliance leader Dale Wahlstrom and others discuss Minnesota's future in biosciences on Minnesota Public Radio. Listen to the hour-long program here.

Bioscience Conference

In February, the Minnesota Partnership hosted a conference on Minnesota's future in the biosciences industry. At the conference, the latest research that clearly shows that the door is still open for Minnesota to advance in this emerging field.

See the presentation

The research, conducted by an economic impact research firm that has tracked bioscience development potential for companies, industries, states and countries around the world offered insight into Minnesota's position in the biosciences - our strengths, challenges and opportunities. A panel of Minnesotans operating bio-businesses in the state demonstrated the economic and job-creation benefits the state's already receiving from the industry. Participants also received an update on the work of the Mayo Clinic-University of Minnesota bioscience partnership, which in just three years has become a nationally recognized model of collaboration for advancing medical research.

See the Partnership Update Presentation

Latest News

Minnesota Partnership Recruits Two Top Researchers

Two more nationally regarded researchers have been recruited to support critical biomedical research in Minnesota, thanks to the Minnesota Partnership for Biotechnology and Medical Genomics. The two faculty investigators have assumed their new positions at Mayo Clinic and the University of Minnesota.

Minnesota Partnership Announces Four Infrastructure Awards $7 million in support of biomedical research

The Minnesota Partnership for Biotechnology and Medical Genomics is awarding $7 million in state-funded infrastructure support to four partnering research teams. The awards will provide equipment and materials for research on congenital heart disease, improved bioinformatics to analyze genomic data, advanced imaging of the brain for numerous diseases and the creation of a crystallization facility to study hundreds of medical conditions at the molecular level.

Minnesota Partnership Advances Potential MS Therapy Clinical-stage manufacturing progressing at Biovest in Minneapolis

A production laboratory founded by the Minnesota Partnership has transferred its first potential therapy — a medication for multiple sclerosis — to a processing plant in Minnesota. This step will complete purification of material to fully enable translation from preclinical to clinical development.